$NKTR News Article - Nektar Announces Promising New and Corrected Rezpegaldesleukin Efficacy Data Which Were Previously Reported in 2022 and Incorrectly Calculated by Former Collaborator Eli Lilly & Company
https://marketwirenews.com/news-releases/nekt...41808.html